Avalo Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold AVTX, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
13
Funds holding
$23027237
Total value held
Buying
8 added/new · 5 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Bank Of America Corp /De/ | $9599990 | 643000 | +21650 | +3.48% |
| 2 | Blackrock, Inc. | $4883335 | 327082 | +37511 | +12.95% |
| 3 | Ameriprise Financial Inc | $2570184 | 172149 | -45825 | -21.02% |
| 4 | Morgan Stanley | $2409583 | 161392 | -103515 | -39.08% |
| 5 | State Street Corp | $1069794 | 71654 | -7600 | -9.59% |
| 6 | Goldman Sachs Group Inc | $897383 | 60106 | -5207 | -7.97% |
| 7 | Sei Investments Co | $848830 | 56854 | — | NEW BUY |
| 8 | Northern Trust Corp | $456201 | 30556 | -1648 | -5.12% |
| 9 | Barclays Plc | $218605 | 14642 | — | NEW BUY |
| 10 | Us Bancorp \De\ | $50568 | 3387 | +654 | +23.93% |
| 11 | Citigroup Inc | $20757 | 1143 | +743 | +185.75% |
| 12 | Royal Bank Of Canada | $2000 | 216 | — | NEW BUY |
| 13 | Amalgamated Financial Corp. | $7 | 9807 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.